We are live on !
Find out more
Emerald Acquisition Portfolio holdings
AUM
$51.8B
Turnover
12.96%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow % of AUM
Cap. Flow %
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.36% |
| 2 | Healthcare | 13.13% |
| 3 | Technology | 12.22% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2501
Group 1 Automotive
GPI
$2.89B
| $355K | ﹤0.01% |
5,561
-3,761
| -40% | -$222K |
2016 Q2
1 quarter
|
|
|
ARA
2502
DELISTED
American Renal Associates Holdings, Inc
ARA
| $353K | ﹤0.01% |
+19,305
| New | +$435K |
2016 Q3
0 quarters
|
|
2503
DELISTED
Barclays Bank Plc
BCS.PRD.CL
| $353K | ﹤0.01% |
13,560
+8,000
| +144% | +$209K |
2016 Q2
1 quarter
|
|
|
ALR
2504
DELISTED
Alere Inc
ALR
| $351K | ﹤0.01% |
8,125
-9,276
| -53% | -$378K |
2016 Q2
1 quarter
|
|
|
FNBC
2505
DELISTED
First NBC Bank Holding Company
FNBC
| $351K | ﹤0.01% |
37,220
-132,330
| -78% | -$1.92M |
2016 Q2
1 quarter
|
|
2506
Community West Bancshares
CWBC
$713M
| $350K | ﹤0.01% |
22,086
+11,999
| +119% | +$182K |
2016 Q2
1 quarter
|
|
2507
Metallus
MTUS
$834M
| $350K | ﹤0.01% |
33,471
-53,112
| -61% | -$528K |
2016 Q2
1 quarter
|
|
2508
Southern Copper
SCCO
$155B
| $349K | ﹤0.01% |
14,499
-28,051
| -66% | -$669K |
2016 Q2
1 quarter
|
|
2509
Evolution Petroleum
EPM
$151M
| $347K | ﹤0.01% |
+55,273
| New | +$316K |
2016 Q3
0 quarters
|
|
|
LORL
2510
DELISTED
Loral Space and Communications, Inc.
LORL
| $347K | ﹤0.01% |
+8,875
| New | +$321K |
2016 Q3
0 quarters
|
|
2511
Gladstone Commercial Corp
GOOD
$581M
| $346K | ﹤0.01% |
+18,532
| New | +$333K |
2016 Q3
0 quarters
|
|
2512
Universal Health Realty Income Trust
UHT
$526M
| $345K | ﹤0.01% |
5,476
-455
| -8% | -$27.5K |
2016 Q2
1 quarter
|
|
2513
CytomX Therapeutics
CTMX
$532M
| $342K | ﹤0.01% |
21,842
-21,842
| -50% | -$264K |
2016 Q2
1 quarter
|
|
2514
Cheetah Mobile
CMCM
$72.9M
| $341K | ﹤0.01% |
5,475
-5,474
| -50% | -$316K |
2016 Q2
1 quarter
|
|
2515
aTyr Pharma
ATYR
$16.7M
| $339K | ﹤0.01% |
7,601
+2,293
| +43% | +$99.1K |
2016 Q2
1 quarter
|
|
2516
DELISTED
Chimerix, Inc.
CMRX
| $339K | ﹤0.01% |
+61,204
| New | +$280K |
2016 Q3
0 quarters
|
|
|
CPHD
2517
DELISTED
Cepheid Inc
CPHD
| $339K | ﹤0.01% |
6,437
-115,690
| -95% | -$4.61M |
2016 Q2
1 quarter
|
|
2518
Transocean
RIG
$6.79B
| $338K | ﹤0.01% |
31,740
-516,974
| -94% | -$5.46M |
2016 Q2
1 quarter
|
|
2519
DELISTED
MANNING & NAPIER, INC.
MN
| $338K | ﹤0.01% |
47,604
+6,899
| +17% | +$55.3K |
2016 Q2
1 quarter
|
|
2520
DELISTED
Dynavax Technologies
DVAX
| $336K | ﹤0.01% |
32,051
-323
| -1% | -$4.64K |
2016 Q2
1 quarter
|
|
|
IL
2521
DELISTED
IntraLinks Holdings Inc.
IL
| $335K | ﹤0.01% |
+33,345
| New | +$282K |
2016 Q3
0 quarters
|
|
|
TNGO
2522
DELISTED
Tangoe, Inc.
TNGO
| $334K | ﹤0.01% |
40,478
-29,564
| -42% | -$254K |
2016 Q2
1 quarter
|
|
2523
Shore Bancshares
SHBI
$780M
| $332K | ﹤0.01% |
28,248
+20,450
| +262% | +$239K |
2016 Q2
1 quarter
|
|
2524
DELISTED
CSRA Inc.
CSRA
| $332K | ﹤0.01% |
12,376
-11,166
| -47% | -$288K |
2016 Q2
1 quarter
|
|
|
JOY
2525
DELISTED
Joy Global Inc
JOY
| $332K | ﹤0.01% |
11,957
-407,447
| -97% | -$10.8M |
2016 Q2
1 quarter
|
|
Similar funds
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.